Standard Maintenance [POMP/D (Methotrexate, 6 - Mercaptopurine, Vincristine, Prednisone/Dexamethasone)] Plus Ixazomib Maintenance Therapy in Adults With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2017
At a glance
- Drugs Ixazomib (Primary) ; Dexamethasone; Mercaptopurine; Methotrexate; Prednisone; Vincristine
- Indications Acute lymphoblastic leukaemia; Lymphoma
- Focus Adverse reactions
- 03 Aug 2017 Status changed from not yet recruiting to recruiting.
- 02 May 2017 Planned initiation date changed from 1 Mar 2017 to 1 Jun 2017.
- 08 Nov 2016 Planned End Date changed from 1 Jan 2021 to 1 Jan 2022.